Fundraising Fox

Transcend Therapeutics

Founded 2021 · 32 employees on LinkedIn · 4 known investors

Transcend Therapeutics develops rapid-acting pharmaceutical treatments for neuropsychiatric diseases, including PTSD and depression, targeting patients unresponsive to current psychiatric medications. The company is a clinical-stage biotech firm focused on neuroscience-based drug development.

BiotechDigital HealthMedical DevicesMental Health

Founders & leadership

Transcend Therapeutics was founded in 2021 by Blake Mandell.

BMBlake Mandell
Blake Mandellin𝕏Co-Founder and ChairmanFounder & CEO at AlleyCorp30 Under 30 2023

Investors · 4

AlleyCorpNew York · $1M – $5M
Alpha Wave GlobalMiami
Emerald Development ManagersNew York
Alley Robotics VenturesreportedCohasset · $500K – $2Mvia Abe Murray · inferred

Frequently asked questions

What does Transcend Therapeutics do?
Transcend Therapeutics develops rapid-acting pharmaceutical treatments for neuropsychiatric diseases, including PTSD and depression, targeting patients unresponsive to current psychiatric medications. The company is a clinical-stage biotech firm focused on neuroscience-based drug development.
Who founded Transcend Therapeutics?
Transcend Therapeutics was founded by Blake Mandell in 2021.
Who are Transcend Therapeutics's investors?
Transcend Therapeutics's investors include AlleyCorp, Alpha Wave Global, Emerald Development Managers, Alley Robotics Ventures.